New treatments for neuromuscular disease: optimism and obstacles.
作者信息
Lochmüller Hanns, Griggs Robert C
出版信息
Neurotherapeutics. 2008 Oct;5(4):497-8. doi: 10.1016/j.nurt.2008.08.010.
Abstract
摘要
相似文献
1
New treatments for neuromuscular disease: optimism and obstacles.神经肌肉疾病的新疗法：乐观与障碍
Neurotherapeutics. 2008 Oct;5(4):497-8. doi: 10.1016/j.nurt.2008.08.010.
2
Too much hype, not enough hope: are balanced reporting and proper controls too much to expect from therapeutic studies in animal models of neuromuscular diseases that presage clinical trials in humans?炒作过多，希望不足：对于预示着人类临床试验的神经肌肉疾病动物模型治疗研究，期待其进行平衡的报道和适当的管控是否过于苛求？
Neuromuscul Disord. 2007 Mar;17(3):203-5. doi: 10.1016/j.nmd.2007.02.001. Epub 2007 Feb 26.
3
Neuromuscular disease: new insights and avenues for therapy.神经肌肉疾病：治疗的新见解与途径
Lancet Neurol. 2013 Jan;12(1):13-5. doi: 10.1016/S1474-4422(12)70298-3.
4
Inherited neuromuscular diseases. Translation from pathomechanisms to therapies.遗传性神经肌肉疾病。从发病机制到治疗方法的转化
Adv Exp Med Biol. 2009;652:v-vi.
5
New therapies for neuromuscular diseases in 2018.2018年神经肌肉疾病的新疗法。
Lancet Neurol. 2019 Jan;18(1):12-13. doi: 10.1016/S1474-4422(18)30414-9.
6
Improving translational studies: lessons from rare neuromuscular diseases.改善转化研究：罕见神经肌肉疾病的经验教训。
Dis Model Mech. 2015 Oct 1;8(10):1175-7. doi: 10.1242/dmm.022616.
7
Gene and splicing therapies for neuromuscular diseases.基因和剪接治疗神经肌肉疾病。
Front Biosci (Landmark Ed). 2015 Jun 1;20(8):1190-233. doi: 10.2741/4367.
8
Mitochondrial dysfunction and neuromuscular disease.
Muscle Nerve. 2001 Feb;24(2):170-91. doi: 10.1002/1097-4598(200102)24:2<170::aid-mus30>3.0.co;2-0.
9
Developing new treatments for muscle disease: prospects and promise.
Curr Opin Neurol. 1994 Oct;7(5):422-6. doi: 10.1097/00019052-199410000-00010.
10
Immunotherapy in autoimmune neuromuscular disorders.
Lancet Neurol. 2003 Jan;2(1):22-32. doi: 10.1016/s1474-4422(03)00264-3.
引用本文的文献
1
Self-reported functioning among patients with ultra-rare nemaline myopathy or a related disorder in Finland: a pilot study.芬兰超罕见杆状体肌病或相关疾病患者的自我报告功能：一项初步研究。
Orphanet J Rare Dis. 2023 Nov 30;18(1):374. doi: 10.1186/s13023-023-02973-2.
2
Combined N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study rationale and protocol.采用贝叶斯方法进行的1对1试验组合，以研究美西律在非营养不良性肌强直中的作用；研究原理与方案。
BMC Neurol. 2015 Mar 25;15:43. doi: 10.1186/s12883-015-0294-4.
本文引用的文献
1
Current status of gene therapy for muscle diseases.肌肉疾病基因治疗的现状
Drug News Perspect. 2007 Jul-Aug;20(6):357-63. doi: 10.1358/dnp.2007.20.6.1138159.
2
Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission.先天性肌无力综合征：聚焦神经肌肉传递的遗传缺陷。
Expert Rev Mol Med. 2007 Aug 9;9(22):1-20. doi: 10.1017/S1462399407000427.
3
Effect of prednisone on protein metabolism in Duchenne dystrophy.泼尼松对杜兴氏肌营养不良症蛋白质代谢的影响。
Am J Physiol. 1995 Jan;268(1 Pt 1):E67-74. doi: 10.1152/ajpendo.1995.268.1.E67.
Zotero 插件